The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

MSD/Merck & Co's headquarters in Rahway, New Jersey. MSD has said it plans to separate its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31 ...

U.S. drugmaker Merck (MSD) on the 3rd (local time) laid out a growth strategy to prepare for the expiration of its immuno-oncology drug Keytruda's patents during its earnings conference call. The ...

Drug giant MSD expects the imminent loss of patent exclusivity on diabetes drug Januvia and other medicines to hit harder ‍than analysts are projecting. The comapny on Tuesday ‍forecast 2026 sales and ...

BDT & MSD Partners is close to acquiring a Four Seasons resort in Orlando from Host Hotels & Resorts Inc. in a rare deal for a hotel located on a Walt Disney Co. property. The investment firm would ...

Merck & Co (MSD) is no longer in talks to acquire oncology biotech Revolution Medicines after negotiations hit a stumbling block over valuations, according to the Wall Street Journal (WSJ). Citing ...

Nearly 50 years ago, in the late 1970s, Autotronic Control Corporation began experimenting with multiple spark discharge (MSD) ignition technology as an alternative to the inductive ignitions used in ...

People facing long delays in getting ACC cover will no longer have to repay supplementary assistance they have received while the awaited ACC's decision following a recent High Court decision.

The National Safety Council’s 2024–2025 MSD Solutions Index Pledge Community Report finds many organizations strengthening safety culture but urges clearer risk-reduction goals and broader adoption of ...

‘Shocking’ is the first word that lawyers working with survivors of abuse in State care can come up with after they were alerted to a serious privacy breach perpetrated by the Ministry of Social ...

CNBC's Robert Frank sits down for a rare and exclusive interview with bankers to America's wealthiest families, Byron Trott and Gregg Lemkau, co-CEOs of BDT & MSD Partners. Got a confidential news tip ...

Enlicitide significantly reduces LDL-C in patients with high cardiovascular risk MSD has announced positive results from its phase 3 CORALreef Lipids trial, showing that enlicitide decanoate, an ...